Resources

Clinical features of limbic encephalitis with LGI1 antibody February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481279/

Learn more
Encephalitis associated with autoantibodies binding to γ-aminobutyric acid-A, γ-aminobutyric acid-B and glycine receptors: immunopathogenic mechanisms and clinical characteristics February 27, 2021

https://nnjournal.net/article/view/1359

Learn more
Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/29703768/

Learn more
Psychiatric symptoms in anti glutamic acid decarboxylase associated limbic encephalitis in adults: a systematic review February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/33022299/

Learn more
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/31326280/

Learn more
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/32221776/

Learn more
Diagnosis and significance of antibody titres in anti-NMDA receptor encephalitis, a retrospective study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006368/

Learn more
Neurologic syndromes related to anti-GAD65, Clinical and serologic response to treatment February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136051/

Learn more
Dr. Anusha Yeshokumar discusses the outcomes after AE at the Texas Support Group meeting. February 27, 2021

Learn more
Glycine receptor autoantibodies disrupt inhibitory neurotransmission February 27, 2021

https://academic.oup.com/brain/article/142/11/3398/5583666

Learn more